Original Research Focus on Geriatric Psychiatry June 2, 2025

Risk of Alzheimer Disease and Vascular Dementia in Patients With Peripheral Vestibular Disorders: A Longitudinal Study of 140,726 Participants

; ; ; ; ; ;

J Clin Psychiatry 2025;86(3):24m15699

Abstract

Objective: The associations between peripheral vestibular disorders (PVDs)—specifically Meniere’s disease, benign paroxysmal positional vertigo (BPPV), vestibular neuritis, and unspecified PVD—and dementia risk are unclear.

Methods: By using data from the Taiwan National Health Insurance Research Database, this study included 70,363 patients aged ≥45 years with PVD between 1998 and 2011. An age-matched control group of 70,363 individuals without PVD was also established. All the included participants were followed up from the time of enrollment until the end of 2013 to assess the risk of dementia-related conditions, including Alzheimer’s disease (AD), vascular dementia, and unspecified dementia.

Results: Cox proportional hazards regression models, adjusted for demographic characteristics and psychiatric comorbidities, revealed that patients with PVD exhibited a significantly elevated risk of any form of dementia during the follow-up period (hazard ratio [HR] = 1.83, 95% CI, 1.69–1.97) compared with the control group. Notably, patients with BPPV exhibited the highest risk of AD (HR = 3.14, 95% CI, 2.35–4.19), followed by Meniere’s disease (HR= 2.79, 95% CI, 2.17–3.59) and vestibular neuritis (HR = 2.66, 95% CI, 2.11–3.35).

Conclusions: PVDs are a risk factor for dementia, regardless of psychiatric comorbidities. Further research is warranted to elucidate the pathophysiological mechanisms underlying the association between PVDs and dementia.

J Clin Psychiatry 2025;86(3):24m15699

Author affiliations are listed at the end of this article.

Members Only Content

This full article is available exclusively to Professional tier members. Subscribe now to unlock the HTML version and gain unlimited access to our entire library plus all PDFs. If you’re already a subscriber, please log in below to continue reading.

Subscribe Now

Already a member? Log in

  1. Cronin T, Arshad Q, Seemungal BM. Vestibular deficits in neurodegenerative disorders: balance, dizziness, and spatial disorientation. Front Neurol. 2017;8:538. PubMed CrossRef
  2. Neuhauser HK, Lempert T. Vertigo: epidemiologic aspects. Semin Neurol. 2009;29(5):473–481. PubMed CrossRef
  3. Strupp M, Mandalà M, López-Escámez JA. Peripheral vestibular disorders: an update. Curr Opin Neurol. 2019;32(1):165–173. PubMed
  4. Hülse R, Biesdorf A, Hörmann K, et al. Peripheral vestibular disorders: an epidemiologic survey in 70 million individuals. .Otol Neurotol. 2019;40(1):88–95.
  5. Hung S-H, Xirasagar S, Dang LH, et al. Trends in the incidence of peripheral vestibular disorders: a nationwide population-based study. Front Neurol. 2023;14:1322199. PubMed CrossRef
  6. Hung SH, Xirasagar S, Dang LH, et al. Trends in the incidence of peripheral vestibular disorders: a Nationwide population-based study. Front Neurol. 2023;14:1322199. PubMed CrossRef
  7. Aedo-Sanchez C, Riquelme-Contreras P, Henríquez F, et al. Vestibular dysfunction and its association with cognitive impairment and dementia. Front Neurosci. 2024;18:1304810. PubMed CrossRef
  8. Pan S, Hu Y, Zhang H, et al. The current status and trends of research related to vestibular disorders, vertigo, and cognitive impairment in the elderly population: a bibliometric analysis. Ear Nose Throat J. 2024:1455613241257396. PubMed CrossRef
  9. Bosmans J, Gommeren H, Gilles A, et al. Evidence of vestibular and balance dysfunction in patients with mild cognitive impairment and Alzheimer’s disease. Ear Hear. 2024;45(1):53–61. PubMed CrossRef
  10. Hebert LE, Scherr PA, Bienias JL, et al. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003;60(8):1119–1122. PubMed CrossRef
  11. Obermann M, Gebauer A, Arweiler-Harbeck D, et al. Cognitive deficits in patients with peripheral vestibular dysfunction. Eur J Neurol. 2025;32(1):e15907. PubMed CrossRef
  12. Li J, Xu X, Deng X, et al. Association of vestibular disorders and cognitive function: a systematic review. Laryngoscope. 2024;134(12):4858–4872. PubMed CrossRef
  13. Bigelow RT, Semenov YR, du Lac S, et al. Vestibular vertigo and comorbid cognitive and psychiatric impairment: the 2008 National Health Interview Survey. J Neurol Neurosurg Psychiatry. 2016;87(4):367–372. PubMed CrossRef
  14. Lim SJ, Son S, Chung Y, et al. Relationship between vestibular loss and the risk of dementia using the 2002-2019 National Insurance Service Survey in South Korea. Sci Rep. 2023;13(1):16746. PubMed CrossRef
  15. Hitier M, Besnard S, Smith PF. Vestibular pathways involved in cognition. Front Integr Neurosci. 2014;8:59. PubMed CrossRef
  16. Wei EX, Oh ES, Harun A, et al. Vestibular loss predicts poorer spatial cognition in patients with Alzheimer’s disease. J Alzheimers Dis. 2018;61(3):995–1003. PubMed CrossRef
  17. Lee IH, Yu H, Ha SS, et al. Association between late-onset Ménière’s disease and the risk of incident all-cause dementia. J Pers Med. 2021;12(1):19. PubMed CrossRef
  18. Lo MH, Lin CL, Chuang E, et al. Association of dementia in patients with benign paroxysmal positional vertigo. Acta Neurol Scand. 2017;135(2):197–203. PubMed CrossRef
  19. Kim SY, Yoo DM, Min C, et al. Increased risk of neurodegenerative dementia after benign paroxysmal positional vertigo. Int J Environ Res Public Health. 2021;18(19):10553. PubMed CrossRef
  20. Hung SH, Chang AH, Cheng YF, et al. Association of young-onset dementia with pre-existing peripheral vestibular disorders. J Alzheimers Dis. 2024;101(2):603–610. PubMed CrossRef
  21. Chen MH, Hsu JW, Huang KL, et al. Risk and coaggregation of major psychiatric disorders among first-degree relatives of patients with bipolar disorder: a nationwide population-based study. Psychol Med. 2019;49(14):2397–2404. PubMed CrossRef
  22. Chen MH, Lan WH, Hsu JW, et al. Risk of developing type 2 diabetes in adolescents and young adults with autism spectrum disorder: a nationwide longitudinal study. Diabetes Care. 2016;39(5):788–793. PubMed CrossRef
  23. Cheng CM, Chang WH, Chen MH, et al. Co-aggregation of major psychiatric disorders in individuals with first-degree relatives with schizophrenia: a nationwide population-based study. Mol Psychiatry. 2018;23(8):1756–1763. PubMed CrossRef
  24. Zhang B, Wang HE, Bai YM, et al. Inflammatory bowel disease is associated with higher dementia risk: a nationwide longitudinal study. Gut. 2021;70(1):85–91. PubMed CrossRef
  25. Hassing LB, Dahl AK, Thorvaldsson V, et al. Overweight in midlife and risk of dementia: a 40-year follow-up study. Int J Obes. 2009;33(8):893–898. PubMed CrossRef
  26. Vuoksimaa E, Rinne JO, Lindgren N, et al. Middle age self-report risk score predicts cognitive functioning and dementia in 20-40 years. Alzheimers Dement (Amst). 2016;4:118–125. PubMed CrossRef
  27. Yang T-H, Xirasagar S, Cheng Y-F, et al. Peripheral vestibular disorders: nationwide evidence from Taiwan. Laryngoscope. 2021;131(3):639–643. PubMed CrossRef
  28. Liu C-Y, Hung Y-T, Chuang Y-L, et al. Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey. J Health Manag. 2006;4:1–22.
  29. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. PubMed CrossRef
  30. Bigelow RT, Agrawal Y. Vestibular involvement in cognition: visuospatial ability, attention, executive function, and memory. J Vestib Res. 2015;25(2):73–89. PubMed CrossRef
  31. Xie D, Welgampola MS, Miller LA, et al. Subjective cognitive dysfunction in patients with dizziness and vertigo. Audiol Neurootol. 2022;27(2):122–132. PubMed CrossRef
  32. Gacek RR. Pathology of benign paroxysmal positional vertigo revisited. Ann Otol Rhinol Laryngol. 2003;112(7):574–582. PubMed CrossRef
  33. Yang WS, Kim SH, Lee JD, et al. Clinical significance of vestibular evoked myogenic potentials in benign paroxysmal positional vertigo. Otol Neurotol. 2008;29(8):1162–1166. PubMed CrossRef
  34. Lyness SA, Zarow C, Chui HC. Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis. Neurobiol Aging. 2003;24:1–23. PubMed CrossRef
  35. Bhattacharyya R, Barman A, Antony F. Influence of BPPV and Meniere’s disease on cognitive abilities: a questionnaire-based study. J Otol. 2024;19(1):10–18. PubMed CrossRef
  36. Rizk HG, Sharon JD, Lee JA, et al. Cross-sectional analysis of cognitive dysfunction in patients with vestibular disorders. Ear Hear. 2020;41(4):1020–1027. PubMed CrossRef
  37. Lupien SJ, de Leon M, de Santi S, et al. Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci. 1998;1:69–73. PubMed CrossRef
  38. Seo YJ, Kim J, Kim SH. The change of hippocampal volume and its relevance with inner ear function in Meniere’s disease patients. Auris Nasus Larynx. 2016;43(6):620–625. PubMed CrossRef
  39. Van Cruijsen N, Hiemstra WM, Meiners LC, et al. Hippocampal volume measurement in patients with Ménière’s disease: a pilot study. Acta Otolaryngol. 2007;127(10):1018–1023. PubMed CrossRef
  40. Guo J, Wang J, Liang P, et al. Vestibular dysfunction leads to cognitive impairments: state of knowledge in the field and clinical perspectives (Review). Int J Mol Med. 2024;53(4):36. PubMed CrossRef
  41. Harun A, Oh ES, Bigelow RT, et al. Vestibular impairment in dementia. Otol Neurotol. 2016;37(8):1137–1142. PubMed CrossRef